Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access

INTRODUCTION: Access to pimavanserin, the only Parkinson disease–related psychosis treatment approved by the FDA, is restricted by insurance requirements, a limited distribution network, and high costs. Following initiation, patients require monitoring for safety and effectiveness. The primary objec...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ment Health Clin
Prif Awduron: Livezey, Sabrina, Shah, Nisha B., McCormick, Robert, DeClercq, Josh, Choi, Leena, Zuckerman, Autumn D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: College of Psychiatric & Neurologic Pharmacists 2021
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120983/
https://ncbi.nlm.nih.gov/pubmed/34026394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2021.05.187
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg